(Q48374603)

11 February 2018

title

Effect of immunomodulatory drugs on in vitro production of brain-derived neurotrophic factor (English)

1 reference

11 February 2018

author name string

H F Petereit

series ordinal

1

1 reference

11 February 2018

H Lindemann

series ordinal

2

1 reference

11 February 2018

S Schoppe

series ordinal

3

1 reference

11 February 2018

publication date

1 February 2003

1 reference

11 February 2018

Multiple Sclerosis Journal

published in

1 reference

11 February 2018

volume

9

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

16-20

1 reference

11 February 2018

Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

BDNF prevents and reverses adult rat motor neuron degeneration and induces axonal outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Simultaneous treatment with BDNF and CNTF after peripheral nerve transection and repair enhances rate of functional recovery compared with BDNF treatment alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Peripheral nerve regeneration and neurotrophic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Neurotrophins and their receptors in nerve injury and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Increased brain-derived neurotrophic factor immunoreactivity in rat dorsal root ganglia and spinal cord following peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Expression of mRNA for brain-derived neurotrophic factor in the dorsal root ganglion following peripheral inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Expression of brain-derived neurotrophic factor protein in activated microglia of human immunodeficiency virus type 1 encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Mechanisms of high-dose intravenous immunoglobulins in demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Pooled human IgG modulates cytokine production in lymphocytes and monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Neurotrophins and cytokines--intermediaries between the immune and nervous systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458503MS869OA

10.1191/1352458503MS869OA

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018